ନାଲବୁଫାଇନ

ଉଇକିପିଡ଼ିଆ‌ରୁ
ନାଲବୁଫାଇନ
Skeletal formula
Ball-and-stick model of nalbuphine
Clinical data
Trade namesNubain, Nalpain, Nalbuphin, others
AHFS/Drugs.commonograph
MedlinePlusa682668
Pregnancy
category
  • B
Routes of
administration
Intravenous, intramuscular, subcutaneous
Legal status
Legal status
  • AU: S4 (Prescription only)
  • CA: Schedule IV
  • US: Rx only (unscheduled) Schedule IV in some states
  • Federally Uncontrolled (RX-only) , except in KY , C-IV
Pharmacokinetic data
BioavailabilityOral: 11% (young adults), >44% (elderly)[୨]
IM: 81% (10 mg), 83% (20 mg)
SC: 76% (20 mg), 79% (10 mg)[୩]
Protein binding50%[୨]
MetabolismLiver (glucuronidation)[୧][୨]
MetabolitesGlucuronide conjugates (inactive), others[୪][୧][୨]
Onset of actionOral: <1 hour[୨]
Rectal: <30 minutes[୨]
IV: 2–3 min[୫]
IM: <15 minutes[୫]
SC: <15 minutes[୫]
Elimination half-life~5 hours (3–6 hours)<[୪]
Duration of action3–4 hours[୬]
ExcretionUrine, bile, feces;[୨] 93% within 6 hours[୭]
Identifiers
  • (–)-17-(cyclobutylmethyl)-4,5α-epoxymorphinan-3,6α,14-triol
ECHA InfoCard100.039.895 Edit this at Wikidata
Chemical and physical data
FormulaC21H27NO4
Molar mass୩୫୭.୪୫ g·mol−1
3D model (JSmol)
  • O[C@@H]4[C@@H]5Oc1c2c(ccc1O)C[C@H]3N(CC[C@]25[C@@]3(O)CC4)CC6CCC6
  • InChI=1S/C21H27NO4/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12/h4-5,12,15-16,19,23-25H,1-3,6-11H2/t15-,16+,19-,20-,21+/m0/s1 checkY
  • Key:NETZHAKZCGBWSS-CEDHKZHLSA-N checkY
  (verify)
<span title="International nonproprietary name (INN): <nowiki>Mr. Ibrahem/Nalbuphine</nowiki>">Mr. Ibrahem/Nalbuphine
Skeletal formula
Ball-and-stick model of nalbuphine
Clinical data
Trade names Nubain, Nalpain, Nalbuphin, others
AHFS/Drugs.com Monograph
MedlinePlus a682668
Pregnancy

category
  • B
Routes of<br><br>administration Intravenous, intramuscular, subcutaneous
Drug class Opioid
Legal status
Legal status
  • <abbr class="country-name" title="<nowiki>Australia</nowiki>">AU: S4 (Prescription only)
  • <abbr class="country-name" title="<nowiki>Canada</nowiki>">CA: Schedule IV
  • <abbr class="country-name" title="<nowiki>United States</nowiki>">US: Rx only (unscheduled) Schedule IV in some states
  • Federally Uncontrolled (RX-only) , except in KY , C-IV
Pharmacokinetic data
Bioavailability • Oral: 11% (young adults), >44% (elderly)

IM</abbr>: 81% (10 mg), 83% (20 mg)

SC</abbr>: 76% (20 mg), 79% (10 mg)
Protein binding 50%
Metabolism Liver (glucuronidation)
Metabolites Glucuronide conjugates (inactive), others
Onset of action • Oral: <1 hour

• Rectal: <30 minutes

IV</abbr>: 2–3 min

IM</abbr>: <15 minutes

SC</abbr>: <15 minutes
Elimination <span class="nowrap">half-life</span> ~5 hours (3–6 hours)<
Duration of action 3–4 hours
Excretion Urine, bile, feces; 93% within 6 hours
Identifiers
IUPAC name
  • (–)-17-(cyclobutylmethyl)-4,5α-epoxymorphinan-3,6α,14-triol
Chemical and physical data
Formula C21H27NO4
Molar mass 357.450 g·mol−1
3D model (JSmol)
SMILES
  • O[C@@H]4[C@@H]5Oc1c2c(ccc1O)C[C@H]3N(CC[C@]25[C@@]3(O)CC4)CC6CCC6
InChI
  • InChI=1S/C21H27NO4/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12/h4-5,12,15-16,19,23-25H,1-3,6-11H2/t15-,16+,19-,20-,21+/m0/s1 checkY
  • Key:NETZHAKZCGBWSS-CEDHKZHLSA-N checkY
  (verify)

ନାଲବୁଫାଇନ, ଅନ୍ୟମାନଙ୍କ ମଧ୍ୟରେ ଏକ ବେପାର ନାମ ନ୍ୟୁବେନ, ବ୍ରାଣ୍ଡ ନାମରେ ବିକ୍ରି ହେଉଥିବା ହେଉଛି ଏକ ଓପିଏଡ୍ ଯାହା ମଧ୍ୟମରୁ ପ୍ରବଳ ଯନ୍ତ୍ରଣାର ଚିକିତ୍ସା ପାଇଁ ବ୍ୟବହୃତ ହୁଏ ।[୫] ଏହା ଏକ ଶିରାରେ, ମାଂସପେଶୀରେ କିମ୍ବା ଚର୍ମ ତଳେ ଇଞ୍ଜେକ୍ସନ ଆକାରରେ ଦିଆଯାଏ ।[୫] ଇଞ୍ଜେକସନ ଦେବାର ୧୫ ମିନିଟ ମଧ୍ୟରେ ପ୍ରଭାବ ଆରମ୍ଭ ହୋଇ ଏବଂ ପ୍ରାୟ ୩ରୁ ୪ ଘଣ୍ଟା ପର୍ଯ୍ୟନ୍ତ ରହିଥାଏ ।[୫] [୬]

ସାଧାରଣ ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟାରେ ନିଦ୍ରା, ଝାଳ ବୋହିବା, ବାନ୍ତି, ମୁଣ୍ଡ ବୁଲାଇବା, ଶୁଖିଲା ପାଟି ଏବଂ ମୁଣ୍ଡବିନ୍ଧା ହୋଇପାରେ ।[୮] ଯେତେବେଳେ ଏହା କମ୍ ମାତ୍ରାରେ କିଛି ଶ୍ୱାସକ୍ରିୟା ଅବସାଦ ସୃଷ୍ଟି କରେ କିନ୍ତୁ ଅଧିକ ମାତ୍ରାରେ ଯଥେଷ୍ଟ ବୃଦ୍ଧି ହୁଏ ନାହିଁ ।[୪] ଅନ୍ୟାନ୍ୟ ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟାରେ ଅପବ୍ୟବହାର ଏବଂ ଆନାଫାଇଲକ୍‌ସିସ ଅନ୍ତର୍ଭୁକ୍ତ ହୋଇପାରେ ।[୮] ଏହା ଆଂଶିକ ଆଗୋନିଷ୍ଟ ପ୍ରକାରର ଏକ ଓପିଓଏଡ୍ । [୮]

ନାଲବୁଫାଇନ ୧୯୬୩ ମସିହାରେ ପ୍ୟାଟେଣ୍ଟ ହୋଇଥିଲେ ଏବଂ ୧୯୭୯ରେ ଯୁକ୍ତରାଷ୍ଟ୍ରରେ ଚିକିତ୍ସା ବ୍ୟବହାର ପାଇଁ ଅନୁମୋଦିତ ହୋଇଥିଲେ ।[୯] ଏହା ଏକ ସାଧାରଣ ଔ ଷଧ ଭାବରେ ଉପଲବ୍ଧ । [୮] ଯୁକ୍ତରାଷ୍ଟ୍ରରେ୨୦୨୧ ସୁଦ୍ଧା ୧୦ ମିଗ୍ରା ମାତ୍ରା ନିମନ୍ତେ ପ୍ରାୟ ୪ ଡଲାର ଖର୍ଚ୍ଚ ହୁଏ ।[୧୦] ଏହାକୁ ଅନେକ ଦେଶରେ ବିକ୍ରି କରାଯାଏ ।[୧୧] ଯୁକ୍ତରାଷ୍ଟ୍ରରେ ଏହା ଏକ ନିୟନ୍ତ୍ରିତ ପଦାର୍ଥ ନୁହେଁ ।[୪]

ଆଧାର[ସମ୍ପାଦନା]

  1. ୧.୦ ୧.୧ Steven D. Waldman (9 June 2011). Pain Management E-Book. Elsevier Health Sciences. pp. 910–. ISBN 978-1-4377-3603-8. Archived from the original on 28 October 2021. Retrieved 24 October 2021.
  2. ୨.୦ ୨.୧ ୨.୨ ୨.୩ ୨.୪ ୨.୫ ୨.୬ Bruno Bissonnette (14 May 2014). Pediatric Anesthesia. PMPH-USA. pp. 398–. ISBN 978-1-60795-213-8. Archived from the original on 28 October 2021. Retrieved 24 October 2021.
  3. Excerpta medica. Section 24: Anesthesiology. 1988. Archived from the original on 2021-10-28. Retrieved 2021-10-24. The mean absolute bioavailability was 81% and 83% for the 10 and 20 mg intramuscular doses, respectively, and 79% and 76% following 10 and 20 mg of subcutaneous nalbuphine.
  4. ୪.୦ ୪.୧ ୪.୨ ୪.୩ Narver HL (March 2015). "Nalbuphine, a non-controlled opioid analgesic, and its potential use in research mice". Lab Anim (NY). 44 (3): 106–10. doi:10.1038/laban.701. PMID 25693108. S2CID 25378355.
  5. ୫.୦ ୫.୧ ୫.୨ ୫.୩ ୫.୪ ୫.୫ Howard S. Smith; Marco Pappagallo (6 September 2012). Essential Pain Pharmacology: The Prescriber's Guide. Cambridge University Press. pp. 343–. ISBN 978-0-521-75910-6. Archived from the original on 28 October 2021. Retrieved 24 October 2021.
  6. ୬.୦ ୬.୧ Greaves, Ian; Porter, Keith; Smith, Jason (7 June 2016). Practical Prehospital Care E-book: The Principles and Practice of Immediate Care (in ଇଂରାଜୀ). Elsevier Health Sciences. p. 166. ISBN 978-0-7020-4896-8. Archived from the original on 13 November 2021. Retrieved 11 November 2021.
  7. Yoo YC, Chung HS, Kim IS, Jin WT, Kim MK (Mar–Apr 1995). "Determination of Nalbuphine in Drug Abusers' Urine". Journal of Analytical Toxicology. 19 (2): 120–123. doi:10.1093/jat/19.2.120. PMID 7769781.
  8. ୮.୦ ୮.୧ ୮.୨ ୮.୩ "Nalbuphine Monograph for Professionals". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 27 January 2021. Retrieved 11 November 2021.
  9. Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery (in ଇଂରାଜୀ). John Wiley & Sons. p. 528. ISBN 9783527607495. Archived from the original on 2021-08-29. Retrieved 2021-10-24.
  10. "Nalbuphine Prices, Coupons & Patient Assistance Programs". Drugs.com (in ଇଂରାଜୀ). Retrieved 11 November 2021.
  11. "Nalbuphine". Archived from the original on 2018-06-18. Retrieved 2021-10-24.